<h1>Krishna Institute of Medical Sciences Issues Corrigendum to EGM Notice Regarding Preferential Issue</h1>
Krishna Institute of Medical Sciences Limited has issued a Corrigendum to the Notice of its Extraordinary General Meeting (EGM). This update addresses clarifications requested by exchanges and rectifies inadvertent typographical errors related to the proposed preferential issue.
The EGM, scheduled for Thursday, 9 July 2026, is set to be held via Video Conferencing (VC) or Other Audio Visual Means (OAVM). The notice relates to Item No. 1 of the agenda, which concerns the company's proposal for a preferential issue of equity shares.
The Corrigendum was issued following observations from the National Stock Exchange (NSE). To incorporate these necessary clarifications and correct typographical mistakes in the original explanatory statement annexed to Item No. 1, the Company has released the updated document.
Key details pertaining to Krishna Institute of Medical Sciences Limited are provided below:
| Identifier | Value |
|---|---|
| NSE Symbol | KIMS |
| BSE Scrip Code | 543308 |
| ISIN | INE967H01025 |
The updated Corrigendum to the EGM Notice and its explanatory statement are available on the company’s website.
KIMS Stock Price Movement
On Friday, shares of Krishna Institute of Medical Sciences Limited edged higher, closing at ₹850.65 after gaining 1.47%. The stock delivered strong performance, achieving an annual high of ₹855.8 and recording a significant trading volume of 561,178 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.